LLY compared with TGTX: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

TGTXTG Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

TGTXTG Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

Q1 FY26±5.3%▲+9.80%×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

TGTX

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±11.4%▼−11.26%×0.99

May 6 '26±8.7%▲+16.26%×1.87

= impliedLLY realized, solidTGTX realized, hatchedOne scale, both sides: full bar = 17%× = |realized| ÷ impliedSource: market data

Q1 FY26

±9.3%

▲+4.18%

×0.45

Q3 FY25±14.9%▼−3.13%×0.21

LLYELI Lilly & Co

1,360.90▼−0.28%· post 1,358.90

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

TGTXTG Therapeutics, Inc.

59.76▲+3.07%· post 59.85

ClosedNov 6 '26

Mkt cap$9.2BRevenue$240MQ2 FY26Revenue$616MFY25

Compare

ClosedNov 6 '26

LLYELI Lilly & Co

TGTXTG Therapeutics, Inc.

1,360.90▼−0.28%post 1,358.90

Price

59.76▲+3.07%post 59.85

$1.2T

Mkt cap

$9.2B

Q3 FY26$24.4B

Revenue

$240MQ2 FY26

FY25$65.2B

Revenue

$616MFY25

LLY1,360.90▼−0.28%vsTGTX59.76▲+3.07%ClosedNov 6 '26